Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer
Nom du journal : Bone Marrow Transplant
Année : 2008
Volume : 41
Page de départ : 555
Page de fin : 562